nodes	percent_of_prediction	percent_of_DWPC	metapath
Cetrorelix—GNRHR—GPCRs, Other—ADGRV1—peripheral nervous system neoplasm	0.0692	0.197	CbGpPWpGaD
Cetrorelix—LHCGR—Arf6 signaling events—HGF—peripheral nervous system neoplasm	0.0261	0.0746	CbGpPWpGaD
Cetrorelix—Local reaction—Tretinoin—peripheral nervous system neoplasm	0.0247	0.0381	CcSEcCtD
Cetrorelix—Local reaction—Isotretinoin—peripheral nervous system neoplasm	0.0247	0.0381	CcSEcCtD
Cetrorelix—Local reaction—Melphalan—peripheral nervous system neoplasm	0.0244	0.0376	CcSEcCtD
Cetrorelix—LHCGR—Arf6 signaling events—MET—peripheral nervous system neoplasm	0.0206	0.0589	CbGpPWpGaD
Cetrorelix—Redness—Isotretinoin—peripheral nervous system neoplasm	0.0203	0.0312	CcSEcCtD
Cetrorelix—Redness—Tretinoin—peripheral nervous system neoplasm	0.0203	0.0312	CcSEcCtD
Cetrorelix—LHCGR—G alpha (s) signalling events—VIP—peripheral nervous system neoplasm	0.0192	0.0549	CbGpPWpGaD
Cetrorelix—Local reaction—Alitretinoin—peripheral nervous system neoplasm	0.0187	0.0289	CcSEcCtD
Cetrorelix—Contusion—Isotretinoin—peripheral nervous system neoplasm	0.0157	0.0242	CcSEcCtD
Cetrorelix—Contusion—Tretinoin—peripheral nervous system neoplasm	0.0157	0.0242	CcSEcCtD
Cetrorelix—Redness—Alitretinoin—peripheral nervous system neoplasm	0.0154	0.0237	CcSEcCtD
Cetrorelix—Injection site reaction—Tretinoin—peripheral nervous system neoplasm	0.0136	0.021	CcSEcCtD
Cetrorelix—Injection site reaction—Isotretinoin—peripheral nervous system neoplasm	0.0136	0.021	CcSEcCtD
Cetrorelix—Injection site reaction—Melphalan—peripheral nervous system neoplasm	0.0134	0.0207	CcSEcCtD
Cetrorelix—GNRHR—G alpha (q) signalling events—NTS—peripheral nervous system neoplasm	0.0122	0.0349	CbGpPWpGaD
Cetrorelix—LHCGR—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.0121	0.0346	CbGpPWpGaD
Cetrorelix—Contusion—Alitretinoin—peripheral nervous system neoplasm	0.0119	0.0183	CcSEcCtD
Cetrorelix—Swelling—Isotretinoin—peripheral nervous system neoplasm	0.0113	0.0173	CcSEcCtD
Cetrorelix—Swelling—Tretinoin—peripheral nervous system neoplasm	0.0113	0.0173	CcSEcCtD
Cetrorelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—peripheral nervous system neoplasm	0.0109	0.0312	CbGpPWpGaD
Cetrorelix—Anaphylactoid reaction—Topotecan—peripheral nervous system neoplasm	0.0104	0.0159	CcSEcCtD
Cetrorelix—Injection site reaction—Alitretinoin—peripheral nervous system neoplasm	0.0103	0.0159	CcSEcCtD
Cetrorelix—LHCGR—G alpha (s) signalling events—GNAS—peripheral nervous system neoplasm	0.00998	0.0285	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00922	0.0263	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.00884	0.0252	CbGpPWpGaD
Cetrorelix—Swelling—Alitretinoin—peripheral nervous system neoplasm	0.00854	0.0131	CcSEcCtD
Cetrorelix—Local reaction—Epirubicin—peripheral nervous system neoplasm	0.0082	0.0126	CcSEcCtD
Cetrorelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.0081	0.0231	CbGpPWpGaD
Cetrorelix—Local reaction—Doxorubicin—peripheral nervous system neoplasm	0.00759	0.0117	CcSEcCtD
Cetrorelix—Redness—Epirubicin—peripheral nervous system neoplasm	0.00673	0.0104	CcSEcCtD
Cetrorelix—Swelling—Etoposide—peripheral nervous system neoplasm	0.00667	0.0103	CcSEcCtD
Cetrorelix—Anaphylactoid reaction—Cisplatin—peripheral nervous system neoplasm	0.00663	0.0102	CcSEcCtD
Cetrorelix—Immune system disorder—Topotecan—peripheral nervous system neoplasm	0.00626	0.00964	CcSEcCtD
Cetrorelix—Redness—Doxorubicin—peripheral nervous system neoplasm	0.00622	0.00958	CcSEcCtD
Cetrorelix—GNRHR—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00617	0.0176	CbGpPWpGaD
Cetrorelix—Immune system disorder—Melphalan—peripheral nervous system neoplasm	0.00613	0.00944	CcSEcCtD
Cetrorelix—Anaphylactoid reaction—Etoposide—peripheral nervous system neoplasm	0.00608	0.00935	CcSEcCtD
Cetrorelix—Erythema—Tretinoin—peripheral nervous system neoplasm	0.00599	0.00921	CcSEcCtD
Cetrorelix—Erythema—Isotretinoin—peripheral nervous system neoplasm	0.00599	0.00921	CcSEcCtD
Cetrorelix—GNRHR—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.00592	0.0169	CbGpPWpGaD
Cetrorelix—GNRHR—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	0.0055	0.0157	CbGpPWpGaD
Cetrorelix—LHCGR—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.00544	0.0155	CbGpPWpGaD
Cetrorelix—Cough—Topotecan—peripheral nervous system neoplasm	0.00527	0.00811	CcSEcCtD
Cetrorelix—Cough—Tretinoin—peripheral nervous system neoplasm	0.00522	0.00804	CcSEcCtD
Cetrorelix—Cough—Isotretinoin—peripheral nervous system neoplasm	0.00522	0.00804	CcSEcCtD
Cetrorelix—LHCGR—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.00521	0.0149	CbGpPWpGaD
Cetrorelix—Cough—Melphalan—peripheral nervous system neoplasm	0.00516	0.00794	CcSEcCtD
Cetrorelix—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.00493	0.00758	CcSEcCtD
Cetrorelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	0.00492	0.014	CbGpPWpGaD
Cetrorelix—Erythema—Dactinomycin—peripheral nervous system neoplasm	0.00489	0.00753	CcSEcCtD
Cetrorelix—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.00489	0.00752	CcSEcCtD
Cetrorelix—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.00489	0.00752	CcSEcCtD
Cetrorelix—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.00482	0.00742	CcSEcCtD
Cetrorelix—LHCGR—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.00473	0.0135	CbGpPWpGaD
Cetrorelix—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.00457	0.00703	CcSEcCtD
Cetrorelix—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.00457	0.00703	CcSEcCtD
Cetrorelix—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.00454	0.00698	CcSEcCtD
Cetrorelix—LHCGR—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.00454	0.0129	CbGpPWpGaD
Cetrorelix—Injection site reaction—Epirubicin—peripheral nervous system neoplasm	0.00451	0.00695	CcSEcCtD
Cetrorelix—Hypotension—Melphalan—peripheral nervous system neoplasm	0.00451	0.00694	CcSEcCtD
Cetrorelix—Injection site reaction—Doxorubicin—peripheral nervous system neoplasm	0.00418	0.00643	CcSEcCtD
Cetrorelix—LHCGR—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.00414	0.0118	CbGpPWpGaD
Cetrorelix—Immune system disorder—Cisplatin—peripheral nervous system neoplasm	0.00401	0.00617	CcSEcCtD
Cetrorelix—Cough—Alitretinoin—peripheral nervous system neoplasm	0.00396	0.00609	CcSEcCtD
Cetrorelix—LHCGR—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.00395	0.0113	CbGpPWpGaD
Cetrorelix—Erythema—Cisplatin—peripheral nervous system neoplasm	0.00387	0.00595	CcSEcCtD
Cetrorelix—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.0037	0.0057	CcSEcCtD
Cetrorelix—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.00367	0.00566	CcSEcCtD
Cetrorelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.00364	0.0104	CbGpPWpGaD
Cetrorelix—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00363	0.00559	CcSEcCtD
Cetrorelix—LHCGR—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.00362	0.0103	CbGpPWpGaD
Cetrorelix—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.0036	0.00554	CcSEcCtD
Cetrorelix—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.0036	0.00554	CcSEcCtD
Cetrorelix—LHCGR—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.00359	0.0102	CbGpPWpGaD
Cetrorelix—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00357	0.00549	CcSEcCtD
Cetrorelix—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00355	0.00547	CcSEcCtD
Cetrorelix—Hot flush—Epirubicin—peripheral nervous system neoplasm	0.00352	0.00542	CcSEcCtD
Cetrorelix—Menopausal symptoms—Epirubicin—peripheral nervous system neoplasm	0.00349	0.00538	CcSEcCtD
Cetrorelix—GNRHR—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.00349	0.00996	CbGpPWpGaD
Cetrorelix—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00348	0.00536	CcSEcCtD
Cetrorelix—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.00346	0.00533	CcSEcCtD
Cetrorelix—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00346	0.00532	CcSEcCtD
Cetrorelix—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00346	0.00532	CcSEcCtD
Cetrorelix—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00341	0.00525	CcSEcCtD
Cetrorelix—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.00341	0.00524	CcSEcCtD
Cetrorelix—Hypotension—Vincristine—peripheral nervous system neoplasm	0.00333	0.00513	CcSEcCtD
Cetrorelix—LHCGR—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.00331	0.00945	CbGpPWpGaD
Cetrorelix—Hot flush—Doxorubicin—peripheral nervous system neoplasm	0.00326	0.00502	CcSEcCtD
Cetrorelix—Menopausal symptoms—Doxorubicin—peripheral nervous system neoplasm	0.00323	0.00498	CcSEcCtD
Cetrorelix—GNRHR—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.00317	0.00904	CbGpPWpGaD
Cetrorelix—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00315	0.00486	CcSEcCtD
Cetrorelix—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.00315	0.00485	CcSEcCtD
Cetrorelix—Rash—Topotecan—peripheral nervous system neoplasm	0.00311	0.00478	CcSEcCtD
Cetrorelix—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.0031	0.00478	CcSEcCtD
Cetrorelix—Cough—Etoposide—peripheral nervous system neoplasm	0.00309	0.00476	CcSEcCtD
Cetrorelix—Headache—Topotecan—peripheral nervous system neoplasm	0.00309	0.00475	CcSEcCtD
Cetrorelix—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00308	0.00474	CcSEcCtD
Cetrorelix—Rash—Tretinoin—peripheral nervous system neoplasm	0.00308	0.00474	CcSEcCtD
Cetrorelix—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00308	0.00474	CcSEcCtD
Cetrorelix—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00308	0.00474	CcSEcCtD
Cetrorelix—Headache—Tretinoin—peripheral nervous system neoplasm	0.00306	0.00471	CcSEcCtD
Cetrorelix—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00306	0.00471	CcSEcCtD
Cetrorelix—Rash—Melphalan—peripheral nervous system neoplasm	0.00304	0.00468	CcSEcCtD
Cetrorelix—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00304	0.00468	CcSEcCtD
Cetrorelix—GNRHR—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.00304	0.00867	CbGpPWpGaD
Cetrorelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	0.00299	0.00853	CbGpPWpGaD
Cetrorelix—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00295	0.00454	CcSEcCtD
Cetrorelix—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00294	0.00453	CcSEcCtD
Cetrorelix—Nausea—Topotecan—peripheral nervous system neoplasm	0.00293	0.0045	CcSEcCtD
Cetrorelix—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.0029	0.00447	CcSEcCtD
Cetrorelix—Nausea—Tretinoin—peripheral nervous system neoplasm	0.0029	0.00447	CcSEcCtD
Cetrorelix—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00289	0.00445	CcSEcCtD
Cetrorelix—Nausea—Melphalan—peripheral nervous system neoplasm	0.00286	0.00441	CcSEcCtD
Cetrorelix—LHCGR—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.00279	0.00798	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.00277	0.00792	CbGpPWpGaD
Cetrorelix—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00273	0.0042	CcSEcCtD
Cetrorelix—Hypotension—Etoposide—peripheral nervous system neoplasm	0.0027	0.00416	CcSEcCtD
Cetrorelix—LHCGR—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.00268	0.00765	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.00264	0.00754	CbGpPWpGaD
Cetrorelix—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00263	0.00405	CcSEcCtD
Cetrorelix—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00262	0.00403	CcSEcCtD
Cetrorelix—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00252	0.00388	CcSEcCtD
Cetrorelix—GNRHR—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.00242	0.00692	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.0024	0.00685	CbGpPWpGaD
Cetrorelix—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00237	0.00365	CcSEcCtD
Cetrorelix—LHCGR—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.00234	0.00668	CbGpPWpGaD
Cetrorelix—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00233	0.00359	CcSEcCtD
Cetrorelix—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00233	0.00359	CcSEcCtD
Cetrorelix—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00232	0.00358	CcSEcCtD
Cetrorelix—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00232	0.00357	CcSEcCtD
Cetrorelix—Rash—Vincristine—peripheral nervous system neoplasm	0.00225	0.00346	CcSEcCtD
Cetrorelix—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00225	0.00346	CcSEcCtD
Cetrorelix—Headache—Vincristine—peripheral nervous system neoplasm	0.00224	0.00344	CcSEcCtD
Cetrorelix—GNRHR—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.00221	0.00632	CbGpPWpGaD
Cetrorelix—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.0022	0.00339	CcSEcCtD
Cetrorelix—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00213	0.00328	CcSEcCtD
Cetrorelix—LHCGR—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.00213	0.00607	CbGpPWpGaD
Cetrorelix—Nausea—Vincristine—peripheral nervous system neoplasm	0.00212	0.00326	CcSEcCtD
Cetrorelix—LHCGR—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.00212	0.00605	CbGpPWpGaD
Cetrorelix—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.00206	0.00317	CcSEcCtD
Cetrorelix—LHCGR—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.00205	0.00584	CbGpPWpGaD
Cetrorelix—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00204	0.00315	CcSEcCtD
Cetrorelix—Rash—Cisplatin—peripheral nervous system neoplasm	0.00199	0.00306	CcSEcCtD
Cetrorelix—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00199	0.00306	CcSEcCtD
Cetrorelix—Erythema—Epirubicin—peripheral nervous system neoplasm	0.00199	0.00306	CcSEcCtD
Cetrorelix—LHCGR—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.00195	0.00558	CbGpPWpGaD
Cetrorelix—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00191	0.00293	CcSEcCtD
Cetrorelix—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00187	0.00288	CcSEcCtD
Cetrorelix—GNRHR—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.00187	0.00534	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.00186	0.00531	CbGpPWpGaD
Cetrorelix—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.00184	0.00283	CcSEcCtD
Cetrorelix—Rash—Etoposide—peripheral nervous system neoplasm	0.00182	0.0028	CcSEcCtD
Cetrorelix—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00182	0.0028	CcSEcCtD
Cetrorelix—Headache—Etoposide—peripheral nervous system neoplasm	0.00181	0.00279	CcSEcCtD
Cetrorelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	0.0018	0.00513	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.00179	0.00512	CbGpPWpGaD
Cetrorelix—Cough—Epirubicin—peripheral nervous system neoplasm	0.00173	0.00267	CcSEcCtD
Cetrorelix—Nausea—Etoposide—peripheral nervous system neoplasm	0.00172	0.00264	CcSEcCtD
Cetrorelix—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00162	0.00249	CcSEcCtD
Cetrorelix—Cough—Doxorubicin—peripheral nervous system neoplasm	0.0016	0.00247	CcSEcCtD
Cetrorelix—GNRHR—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.00157	0.00447	CbGpPWpGaD
Cetrorelix—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.00151	0.00233	CcSEcCtD
Cetrorelix—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.0015	0.00231	CcSEcCtD
Cetrorelix—LHCGR—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.00147	0.00419	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.00142	0.00406	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.00142	0.00405	CbGpPWpGaD
Cetrorelix—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.0014	0.00216	CcSEcCtD
Cetrorelix—GNRHR—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.00137	0.00391	CbGpPWpGaD
Cetrorelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	0.00131	0.00375	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.00131	0.00374	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.00129	0.00369	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.00126	0.00358	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.00124	0.00355	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.0012	0.00342	CbGpPWpGaD
Cetrorelix—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.00119	0.00184	CcSEcCtD
Cetrorelix—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.00115	0.00176	CcSEcCtD
Cetrorelix—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.0011	0.0017	CcSEcCtD
Cetrorelix—LHCGR—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.0011	0.00313	CbGpPWpGaD
Cetrorelix—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.00106	0.00163	CcSEcCtD
Cetrorelix—Rash—Epirubicin—peripheral nervous system neoplasm	0.00102	0.00157	CcSEcCtD
Cetrorelix—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00102	0.00157	CcSEcCtD
Cetrorelix—Headache—Epirubicin—peripheral nervous system neoplasm	0.00101	0.00156	CcSEcCtD
Cetrorelix—GNRHR—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000983	0.00281	CbGpPWpGaD
Cetrorelix—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000962	0.00148	CcSEcCtD
Cetrorelix—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000945	0.00145	CcSEcCtD
Cetrorelix—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000944	0.00145	CcSEcCtD
Cetrorelix—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000939	0.00145	CcSEcCtD
Cetrorelix—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00089	0.00137	CcSEcCtD
Cetrorelix—GNRHR—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000865	0.00247	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000841	0.0024	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000801	0.00229	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000777	0.00222	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000763	0.00218	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000735	0.0021	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000603	0.00172	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000568	0.00162	CbGpPWpGaD
Cetrorelix—LHCGR—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000552	0.00158	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000547	0.00156	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.00052	0.00148	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000511	0.00146	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000502	0.00143	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000459	0.00131	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000427	0.00122	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000404	0.00115	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.00038	0.00109	CbGpPWpGaD
Cetrorelix—GNRHR—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.00037	0.00106	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000366	0.00105	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—TP53—peripheral nervous system neoplasm	0.000351	0.001	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000336	0.000959	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.000336	0.000958	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000307	0.000877	CbGpPWpGaD
Cetrorelix—LHCGR—Signaling Pathways—AKT1—peripheral nervous system neoplasm	0.000296	0.000846	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000286	0.000817	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—TP53—peripheral nervous system neoplasm	0.000235	0.000671	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.000225	0.000641	CbGpPWpGaD
Cetrorelix—GNRHR—Signaling Pathways—AKT1—peripheral nervous system neoplasm	0.000198	0.000566	CbGpPWpGaD
